VisionGate Eyes IPO and Plans to Hire 200 New Employees
VisionGate Inc., the Phoenix-based developer of a 3D cell microscope to detect lung cancer at its earliest stages, is quietly making moves to go public.
Alan Nelson, founder, chairman and CEO of VisionGate, said he's going to need about $75 million to take the company to the next level, which includes making more fully automated 3D microscopes that can see cells in 3D — much like a CT scanner for the whole body. So far, the company has five of them.
So far, he's raised $25 million — all angel investors and no venture capital — and said the next step is to file an initial public offering to raise another $75 million.
Help employers find you! Check out all the jobs and post your resume.
Alan Nelson, founder, chairman and CEO of VisionGate, said he's going to need about $75 million to take the company to the next level, which includes making more fully automated 3D microscopes that can see cells in 3D — much like a CT scanner for the whole body. So far, the company has five of them.
So far, he's raised $25 million — all angel investors and no venture capital — and said the next step is to file an initial public offering to raise another $75 million.
Help employers find you! Check out all the jobs and post your resume.